A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis

• Authors: ROSSEL R.; POLTORATSKIY M.; HOCHAMIR M.; LAKTINOV K.K.; RAMLAU R.; ALONSO M.; GARCIA S.; SKŘIČKOVÁ Jana; PIOVANO P.L.; RIZZATO S.; BIDOLI P.; KOWALSKI D.; CLEMENTI L.; CSECH A.; DE MARINIS F.
• Year of publication: 2019
• Type: Conference abstract